Search Results - Sablin, KS

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Structural change and economic growth in modern Russia: The role of "resource-type" regions

    Structural change and economic growth in modern Russia: The role of "resource-type" regions by Levin, SN, Kislitsyn, DV, Sablin, KS

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

    A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic bre... by Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P6-21-01: Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR+) locally advanced/metastatic breast cancer (LA/mBC): Randomized phase 2 results

    Abstract P6-21-01: Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR+... by Crown, J, Sablin, M-P, Cortés, J, Bergh, J, Im, S-A, Lu, Y-S, Martínez, N, Neven, P, Lee, KS, Morales, S, Pérez-Fidalgo, JA, Adamson, D, Goncalves, A, Prat, A, Jerusalem, G, Schlieker, L, Espadero, R-M, Bogenrieder, T, Chin-Lun Huang, D, Schmid, P

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Xentuzumab (BI 836845), an IGF-neutralizing antibody, combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer: Randomized Phase 2 Results

    Xentuzumab (BI 836845), an IGF-neutralizing antibody, combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer: Ran... by Crown, J, Sablin, MP, Cortes, J, Bergh, J, Im, SA, Lu, YS, Martinez, N, Neven, P, Lee, KS, Morales, S, Perez-Fidalgo, JA, Adamson, D, Goncalves, A, Prat, A, Jerusalem, G, Schlieker, L, Espadero, RM, Bogenrieder, T, Huang, DCL, Schmid, P

    Get full text
    Conference Proceeding
    Save to List
    Saved in:
  5. 5
    Xentuzumab (BI 836845), an IGF-neutralizing antibody, combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer: Randomised phase 2 results

    Xentuzumab (BI 836845), an IGF-neutralizing antibody, combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer: Ran... by Crown, J, Sablin, MP, Cortes, J, Bergh, J, Im, SA, Lu, YS, Martinez, N, Neven, P, Lee, KS, Morales, S, Perez-Fidalgo, JA, Adamson, D, Goncalves, A, Prat, A, Jerusalem, G, Schlieker, L, Espadero, RM, Bogenrieder, T, Huang, DCL, Schmid, P

    Get full text
    Conference Proceeding
    Save to List
    Saved in:
  6. 6
    Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer (LA/mBC): Randomized phase 2 results

    Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally adva... by Crown, J, Sablin, MP, Cortes, J, Bergh, J, Im, SA, Lu, YS, Martinez, N, Neven, P, Lee, KS, Morales, S, Perez-Fidalgo, JA, Adamson, D, Goncalves, A, Prat, A, Jerusalem, G, Schlieker, L, Espadero, RM, Bogenrieder, T, Huang, DCL, Schmid, P

    Get full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: